Skip to main content
. Author manuscript; available in PMC: 2017 May 3.
Published in final edited form as: Heart. 2013 Jul 19;99(22):1675–1680. doi: 10.1136/heartjnl-2013-303926

Table 3. Summary of Imaging Endpoints.

Baseline volume mm3 18 month volume mm3 Slope mm3/month or %/month p-value (within group) p-value (between groups)
ICA Wall volume*
Statins + Placebo 660 ± 230 590 ± 150 -0.5% (0.2%) 0.004 0.49
Statins + Niacin 690 ± 240 590 ± 140 -0.7% (0.2%) 0.0002
ICA Lumen
Statins + Placebo 700 ± 280 700 ± 270 -0.2 (0.9) 0.81 0.98
Statins + Niacin 720 ± 250 720 ± 250 -0.2 (0.9) 0.84
ICA Lipid Core
Statins + Placebo 47 ± 36 54 ± 42 0.2 (0.4) 0.66 0.13
Statins + Niacin 47 ± 37 33 ± 24 -0.8 (0.5) 0.10
CC Wall volume*
Statins + Placebo 110 ± 40 100 ± 20 -0.1% (0.2%) 0.52 0.26
Statins + Niacin 120 ± 40 100 ± 20 -0.4% (0.2%) 0.03
CC Lumen
Statins + Placebo 140 ± 40 150 ± 40 0.05 (0.1) 0.76 0.97
Statins + Niacin 160 ± 40 160 ± 40 0.04 (0.2) 0.80
*

log transformed.

Volumes are presented as means ± standard deviation. Values in parentheses represent standard error. ICA denotes internal carotid artery. CC denotes common carotid artery.